Report Summary
Eternity Insights has published a new study on Global Molecular Biomarkers For Cancer Detection And Management Market focusing on key segments as by Type (Screening, Detection, Risk Assessment, and Monitoring Biomarkers,Prognosis and Prediction Biomarkers,Companion Diagnostic Biomarkers), by Application (Hospital,Research Institutions,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Molecular Biomarkers For Cancer Detection And Management Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Molecular Biomarkers For Cancer Detection And Management Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Molecular Biomarkers For Cancer Detection And Management Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Molecular Biomarkers For Cancer Detection And Management Market Segmentation:
Molecular Biomarkers For Cancer Detection And Management Market, By Type
- Screening
- Detection
- Risk Assessment
- and Monitoring Biomarkers
- Prognosis and Prediction Biomarkers
- Companion Diagnostic Biomarkers
Molecular Biomarkers For Cancer Detection And Management Market, By Application
- Hospital
- Research Institutions
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Molecular Biomarkers For Cancer Detection And Management market in terms of demand generation. The Molecular Biomarkers For Cancer Detection And Management market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Molecular Biomarkers For Cancer Detection And Management market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Molecular Biomarkers For Cancer Detection And Management Market Taxonomy:
To learn more about this report
Global Molecular Biomarkers For Cancer Detection And Management Market Competitive Landscape
The global Molecular Biomarkers For Cancer Detection And Management market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Foundation Medicine
- Gen-Probe
- Genomic Health
- DiagnoCure
- Alere
- Abbott
- BioCept
- Epic Sciences
- Molecular Response
- BioTheranostics
- Life Technologies
- Biophysical
- PGD
- Genomic Health
- GenomeDx
- Atossa Genetics
- 20/20 GeneSystems
- Nodality
- Cynvenio
- Dako (Agilent)
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Screening, Detection, Risk Assessment, and Monitoring Biomarkers,Prognosis and Prediction Biomarkers,Companion Diagnostic Biomarkers |
| By Application Outlook |
Hospital,Research Institutions,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Foundation Medicine,Gen-Probe,Genomic Health,DiagnoCure,Alere,Abbott,BioCept,Epic Sciences,Molecular Response,BioTheranostics,Life Technologies,Biophysical,PGD,Genomic Health,GenomeDx,Atossa Genetics,20/20 GeneSystems,Nodality,Cynvenio,Dako (Agilent) |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Global Molecular Biomarkers For Cancer Detection And Management Industry Market Research Report
1 Molecular Biomarkers For Cancer Detection And Management Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Molecular Biomarkers For Cancer Detection And Management
1.3 Molecular Biomarkers For Cancer Detection And Management Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Molecular Biomarkers For Cancer Detection And Management Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Molecular Biomarkers For Cancer Detection And Management
1.4.2 Applications of Molecular Biomarkers For Cancer Detection And Management
1.4.3 Research Regions
1.4.3.1 North America Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Molecular Biomarkers For Cancer Detection And Management Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Molecular Biomarkers For Cancer Detection And Management
1.5.1.2 Growing Market of Molecular Biomarkers For Cancer Detection And Management
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Molecular Biomarkers For Cancer Detection And Management Analysis
2.2 Major Players of Molecular Biomarkers For Cancer Detection And Management
2.2.1 Major Players Manufacturing Base and Market Share of Molecular Biomarkers For Cancer Detection And Management in 2018
2.2.2 Major Players Product Types in 2018
2.3 Molecular Biomarkers For Cancer Detection And Management Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Molecular Biomarkers For Cancer Detection And Management
2.3.3 Raw Material Cost of Molecular Biomarkers For Cancer Detection And Management
2.3.4 Labor Cost of Molecular Biomarkers For Cancer Detection And Management
2.4 Market Channel Analysis of Molecular Biomarkers For Cancer Detection And Management
2.5 Major Downstream Buyers of Molecular Biomarkers For Cancer Detection And Management Analysis
3 Global Molecular Biomarkers For Cancer Detection And Management Market, by Type
3.1 Global Molecular Biomarkers For Cancer Detection And Management Value ($) and Market Share by Type (2014-2019)
3.2 Global Molecular Biomarkers For Cancer Detection And Management Production and Market Share by Type (2014-2019)
3.3 Global Molecular Biomarkers For Cancer Detection And Management Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Molecular Biomarkers For Cancer Detection And Management Price Analysis by Type (2014-2019)
4 Molecular Biomarkers For Cancer Detection And Management Market, by Application
4.1 Global Molecular Biomarkers For Cancer Detection And Management Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Molecular Biomarkers For Cancer Detection And Management Consumption and Growth Rate by Application (2014-2019)
5 Global Molecular Biomarkers For Cancer Detection And Management Production, Value ($) by Region (2014-2019)
5.1 Global Molecular Biomarkers For Cancer Detection And Management Value ($) and Market Share by Region (2014-2019)
5.2 Global Molecular Biomarkers For Cancer Detection And Management Production and Market Share by Region (2014-2019)
5.3 Global Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Molecular Biomarkers For Cancer Detection And Management Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Molecular Biomarkers For Cancer Detection And Management Consumption by Regions (2014-2019)
6.2 North America Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.3 Europe Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.4 China Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.5 Japan Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.7 India Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
6.8 South America Molecular Biomarkers For Cancer Detection And Management Production, Consumption, Export, Import (2014-2019)
7 Global Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis by Regions
7.1 North America Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.2 Europe Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.3 China Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.4 Japan Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.5 Middle East & Africa Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.6 India Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
7.7 South America Molecular Biomarkers For Cancer Detection And Management Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Foundation Medicine
8.2.1 Company Profiles
8.2.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.2.3 Foundation Medicine Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Foundation Medicine Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.3 Gen-Probe
8.3.1 Company Profiles
8.3.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.3.3 Gen-Probe Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Gen-Probe Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.4 Genomic Health
8.4.1 Company Profiles
8.4.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.4.3 Genomic Health Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 Genomic Health Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.5 DiagnoCure
8.5.1 Company Profiles
8.5.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.5.3 DiagnoCure Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 DiagnoCure Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.6 Alere
8.6.1 Company Profiles
8.6.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.6.3 Alere Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Alere Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.7 Abbott
8.7.1 Company Profiles
8.7.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.7.3 Abbott Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Abbott Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.8 BioCept
8.8.1 Company Profiles
8.8.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.8.3 BioCept Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 BioCept Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.9 Epic Sciences
8.9.1 Company Profiles
8.9.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.9.3 Epic Sciences Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 Epic Sciences Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.10 Molecular Response
8.10.1 Company Profiles
8.10.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.10.3 Molecular Response Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 Molecular Response Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.11 BioTheranostics
8.11.1 Company Profiles
8.11.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.11.3 BioTheranostics Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 BioTheranostics Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.12 Life Technologies
8.12.1 Company Profiles
8.12.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.12.3 Life Technologies Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 Life Technologies Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.13 Biophysical
8.13.1 Company Profiles
8.13.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.13.3 Biophysical Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Biophysical Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.14 PGD
8.14.1 Company Profiles
8.14.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.14.3 PGD Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 PGD Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.15 Genomic Health
8.15.1 Company Profiles
8.15.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.15.3 Genomic Health Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Genomic Health Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.16 GenomeDx
8.16.1 Company Profiles
8.16.2 Molecular Biomarkers For Cancer Detection And Management Product Introduction
8.16.3 GenomeDx Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 GenomeDx Market Share of Molecular Biomarkers For Cancer Detection And Management Segmented by Region in 2018
8.17 Atossa Genetics
8.18 20/20 GeneSystems
8.19 Nodality
8.20 Cynvenio
8.21 Dako (Agilent)
9 Global Molecular Biomarkers For Cancer Detection And Management Market Analysis and Forecast by Type and Application
9.1 Global Molecular Biomarkers For Cancer Detection And Management Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 Type 1 Market Value ($) and Volume Forecast (2019-2026)
9.1.2 Type 2 Market Value ($) and Volume Forecast (2019-2026)
9.1.3 Type 3 Market Value ($) and Volume Forecast (2019-2026)
9.1.4 Type 4 Market Value ($) and Volume Forecast (2019-2026)
9.1.5 Type 5 Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Molecular Biomarkers For Cancer Detection And Management Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Application 1 Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Application 2 Market Value ($) and Volume Forecast (2019-2026)
9.2.3 Application 3 Market Value ($) and Volume Forecast (2019-2026)
9.2.4 Application 4 Market Value ($) and Volume Forecast (2019-2026)
9.2.5 Application 5 Market Value ($) and Volume Forecast (2019-2026)
10 Molecular Biomarkers For Cancer Detection And Management Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
